Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 12:12:goae028.
doi: 10.1093/gastro/goae028. eCollection 2024.

Unraveling the role of tumor sidedness in prognosis of stage II colon cancer

Affiliations

Unraveling the role of tumor sidedness in prognosis of stage II colon cancer

Yun Yang et al. Gastroenterol Rep (Oxf). .

Abstract

Background: Stage II colon cancer has varying risks for metastasis, and treatment strategies depend on molecular and clinicopathological features. While tumor-sidedness is a well-accepted prognostic factor for stage III/IV colon cancer, its role in stage II is controversial. Understanding its effect in stage II is crucial for improving treatment strategies.

Methods: We analyzed clinical and follow-up data of colon cancer from the Surveillance, Epidemiology, and End Results database (2004-2017). Patients were divided into a primary study cohort (2010-2017) and a validation cohort (2004-2009). The baseline characteristics between right-sided colon cancer (RCC) and left-sided colon cancer (LCC) groups were compared. Moreover, the effect of tumor size on cancer-specific survival (CSS) was evaluated using Kaplan-Meier analysis.

Results: The study involved 87,355 patients in the study cohort and 65,858 in the validation cohort. Of the study cohort, 52.3% were diagnosed with RCC. The median age was 64 years old, with 48.5% females and 76.8% of white people. In addition, stage II RCC showed better CSS compared with LCC (5-year CSS 88.0% vs 85.5%, P < 0.001), while stage III/IV RCC demonstrated poorer outcomes. Multivariate Cox regression analysis identified that the right-sidedness was a positive prognostic factor in stages I/II but negative in stages III (HR 1.10, P < 0.001) and IV (HR 1.26, P < 0.001). Chemotherapy rates decreased in RCC, particularly in stage II (RCC vs LCC: 16.2% vs 28.5%, P < 0.001). Subgroup analysis, stratified by T3/T4 stages and chemotherapy status, further highlighted better survival outcomes in RCC.

Conclusions: RCC is associated with a significantly better prognosis in stage II. The importance of considering tumor-sidedness in clinical decision-making and the design of future clinical trials should be emphasized.

Keywords: colonic neoplasms; right-sided colon cancer; stage II; survival; tumor-sidedness.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Kaplan-Meier curve of prognosis difference between right-sided and left-sided colon cancer across four stages for patients diagnosed between 2010 and 2017. (A) Stage I. (B) Stage II. (C) Stage III. (D) Stage IV.
Figure 2.
Figure 2.
Kaplan-Meier curve of prognosis difference between right-sided and left-sided colon cancer across four stages for patients diagnosed between 2004 and 2009. (A) Stage I. (B) Stage II. (C) Stage III. (D) Stage IV.
Figure 3.
Figure 3.
Subgroup survival analysis of stage II patients stratified by T stage and chemotherapy status. Kaplan-Meier survival curve comparing the prognosis of RCC and LCC in (A) T3N0M0, (B) T4N0M0 patients, Kaplan-Meier curve of prognosis of RCC and LCC stratified by chemotherapy status, in (C) T3N0M0, and (D) T4N0M0 patients. CSS = cancer-specific survival, RCC = right-sided colon cancer, LCC = left-sided colon cancer, Chemo. = chemotherapy.

References

    1. Qi J, Li M, Wang L. et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health 2023;8:e943–55. - PubMed
    1. Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. - PubMed
    1. Taieb J, Karoui M, Basile D.. How I treat stage II colon cancer patients. ESMO Open 2021;6:100184. - PMC - PubMed
    1. Lee MS, Menter DG, Kopetz S.. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw 2017;15:411–9. - PubMed
    1. Chang GJ, Gonen M.. Prognostic and predictive ability of tumor sidedness: another vexing difference between localized and advanced colon cancer. JAMA Oncol 2017;3:1314–5. - PubMed